UK
Ireland
Scotland
London
The University of Birmingham has unveiled plans for a new £210 million Health Innovation Campus in the Midlands.
The Campus will be the only science park in the Midlands dedicated to translational health and life sciences research and will sit at the heart of an already well-established critical cluster of health excellence led by Birmingham Health Partners (BHP), University Hospitals Birmingham and Birmingham Women's and Children's.
The development of the 10-acre Birmingham Health Innovation Campus is being delivered through a long-term collaboration between the University and the UK's leading property provider for the science and technology sector, Bruntwood SciTech, a 50:50 joint venture between Bruntwood and Legal & General.
The Campus will provide up to 657,000 sq ft state-of-the-art lab, office and incubation space providing co-location opportunities for all stages of health and life science businesses. The first phase includes a 133,000 sq ft, six-storey building housing a new innovation centre – the Precision Health Technologies Accelerator (PHTA) - that will bring together the leading strengths of the region in genomics and diagnostics for healthcare technologies development and evaluation, clinical trials and healthcare data and informatics. The PHTA will provide a range of prototyping, incubation and laboratory facilities for early-stage businesses and access to business support to develop and rapidly bring innovations to market.
The first phase building will also provide space for larger, more established SMEs and scaleups working in medtech, precision medicine, diagnostics and digital healthcare, creating a thriving cluster of businesses working together and in collaboration with the surrounding clinical and academic community.
The 10-acre site has already received development funding from Birmingham City Council and the Greater Birmingham and Solihull Local Enterprise Partnership and has been designated a Life Science Opportunity Zone by the Department for Business, Energy and Industrial Strategy (BEIS). It will catalyse the development of a new high-growth life sciences cluster for the city and region and by 2030 Birmingham Health Innovation Campus will have seen £210m investment, creating around 10,000 new jobs, and delivering more than £400m GVA to the local economy.
Professor Tim Jones, University of Birmingham Provost and Vice-Principal, explained: "With access to Birmingham’s world-class genomics laboratories, health data programmes, healthcare technology development teams, clinical trials leadership and academic expertise, Birmingham Health Innovation Campus will become the ideal place for innovative health and life sciences businesses to thrive.
"This ambitious new development will leverage the existing integrated BHP ecosystem to drive innovation and economic growth – all centred on a shared mission to transform the health of all citizens, in Birmingham and beyond, by accelerating the development and adoption of healthcare innovations."
Dr David Hardman, Managing Director of Bruntwood SciTech, commented: "This is a huge opportunity for the UK’s life science sector. By creating an environment that will not only help businesses to form, scale, collaborate and grow, we will establish a new thriving life sciences hub, which will create much needed capacity for the West Midlands and help to attract further international investment to the region and beyond.
"Working alongside Birmingham Health Partners, Birmingham Health Innovation Campus will help to align academic, NHS and industry capabilities. It will also provide additional much-needed world class facilities for pioneering healthcare businesses and will bolster the UK’s position as a life sciences leader on the global stage."
